We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

27 hedge funds and large institutions have $9.18M invested in ImmuCell in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more capital invested

Capital invested by funds: $7.04M → $9.18M (+$2.14M)

0.92% more ownership

Funds ownership: 11.37% → 12.29% (+0.92%)

7% less funds holding

Funds holding: 29 → 27 (-2)

10% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 10

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
27
Holders Change
-2
Holders Change %
-6.9%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
9
Reduced
10
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SRC
Shufro Rose & Co
New York
+$553K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$320K
3
Morgan Stanley
Morgan Stanley
New York
+$88.9K
4
BL
Bleichroeder LP
New York
+$76.1K
5
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
+$8.63K

Top Sellers

Rank Fund Capital Flow
1
OMC
Overbrook Management Corp
New York
-$255K
2
Renaissance Technologies
Renaissance Technologies
New York
-$113K
3
PCM
Perritt Capital Management
Illinois
-$30.3K
4
EFS
Essex Financial Services
Connecticut
-$14.8K
5
Koshinski Asset Management
Koshinski Asset Management
Illinois
-$8.63K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.97M +$320K +37,081 +22%
Renaissance Technologies
2
Renaissance Technologies
New York
$1.49M -$113K -13,037 -8%
MFW
3
Meristem Family Wealth
Minnesota
$825K – – –
SRC
4
Shufro Rose & Co
New York
$792K +$553K +64,137 +358%
BL
5
Bleichroeder LP
New York
$686K +$76.1K +8,824 +14%
Morgan Stanley
6
Morgan Stanley
New York
$644K +$88.9K +10,300 +18%
OMC
7
Overbrook Management Corp
New York
$443K -$255K -29,593 -39%
PCM
8
Perritt Capital Management
Illinois
$352K -$30.3K -3,506 -9%
SFS
9
Strategic Financial Services
New York
$299K +$8.39K +972 +3%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$218K +$1.99K +230 +1%
Dimensional Fund Advisors
11
Dimensional Fund Advisors
Texas
$187K – – –
HighTower Advisors
12
HighTower Advisors
Illinois
$177K +$863 +100 +0.5%
FHA
13
Flagship Harbor Advisors
Massachusetts
$157K -$4.32K -500 -3%
WE
14
Wealth Effects
Massachusetts
$151K -$1.73K -200 -1%
PP
15
Prosperity Planning
Missouri
$145K – – –
BlackRock
16
BlackRock
New York
$143K -$5.81K -673 -4%
Northern Trust
17
Northern Trust
Illinois
$128K +$431 +50 +0.4%
MA
18
Minerva Advisors
Pennsylvania
$113K – – –
EFS
19
Essex Financial Services
Connecticut
$106K -$14.8K -1,718 -14%
HPC
20
HM Payson & Co
Maine
$78K – – –
Bank of America
21
Bank of America
North Carolina
$20K -$86 -10 -0.5%
UBS Group
22
UBS Group
Switzerland
$19K -$3.3K -382 -16%
Koshinski Asset Management
23
Koshinski Asset Management
Illinois
$13.5K -$8.63K -1,000 -42%
CAPTRUST Financial Advisors
24
CAPTRUST Financial Advisors
North Carolina
$12K +$8.63K +1,000 +500%
US Bancorp
25
US Bancorp
Minnesota
$6K – – –
1
2

ICCC Hedge Fund Activity: Q1 2022 in Review

27 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q1 2022, worth a combined $9.18M — up 30% from $7.04M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ICCC and 0 opened new positions — a net loss of 2 holders — while 10 trimmed existing stakes and 9 added.

The largest buyer was Shufro Rose & Co, adding an estimated $553K. The largest seller was Overbrook Management Corp, cutting an estimated $255K.

  • 27 institutional investors held ImmuCell (ICCC) as of Q1 2022, down from 29 in Q4 2021.
  • Funds reported $9.18M of ImmuCell stock for Q1 2022, up 30% quarter-over-quarter.
  • 0 funds opened new ImmuCell positions in Q1 2022 and 2 closed out, a net change of -2 holders.
  • The largest ImmuCell buyer in Q1 2022 was Shufro Rose & Co, an estimated $553K added.
  • The largest ImmuCell seller in Q1 2022 was Overbrook Management Corp, an estimated $255K sold.

Based on aggregated 13F filings for Q1 2022.